Related references
Note: Only part of the references are listed.Metabolism-Related Proteins Are Differentially Expressed according to the Molecular Subtype of Invasive Breast Cancer Defined by Surrogate Immunohistochemistry
Junjeong Choi et al.
PATHOBIOLOGY (2013)
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
Wen Cai Zhang et al.
CELL (2012)
Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation
Mohit Jain et al.
SCIENCE (2012)
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato et al.
NATURE (2011)
Molecular Stratification of Triple-Negative Breast Cancers
Charles M. Perou
ONCOLOGIST (2011)
PHGDH amplification and altered glucose metabolism in human melanoma
Edouard Mullarky et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Ketones and lactate fuel tumor growth and metastasis Evidence that epithelial cancer cells use oxidative mitochondrial metabolism
Gloria Bonuccelli et al.
CELL CYCLE (2010)
Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the reverse Warburg effect A transcriptional informatics analysis with validation
Stephanos Pavlides et al.
CELL CYCLE (2010)
Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer
Kyu Yeoun Won et al.
HUMAN PATHOLOGY (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The reverse Warburg effect Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Stephanos Pavlides et al.
CELL CYCLE (2009)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Measurement of Glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer
BL Stackhouse et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Share Paper
